| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma
|
Marec-Berard, Perrine
|
|
|
125 |
C |
p. 58-68
|
artikel
|
| 2 |
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
|
Pautier, P.
|
|
|
125 |
C |
p. 31-37
|
artikel
|
| 3 |
C3 glomerulonephritis in a patient treated with anti–PD-1 antibody
|
Ville, Simon
|
|
|
125 |
C |
p. 46-48
|
artikel
|
| 4 |
Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer
|
Rusan, Maria
|
|
|
125 |
C |
p. 121-129
|
artikel
|
| 5 |
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database
|
Delanoy, Nicolas
|
|
|
125 |
C |
p. 153-163
|
artikel
|
| 6 |
Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma
|
Amaral, Teresa M.S.
|
|
|
125 |
C |
p. 38-45
|
artikel
|
| 7 |
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial
|
Conforti, Fabio
|
|
|
125 |
C |
p. 94-103
|
artikel
|
| 8 |
Immune checkpoint blockade for non–small cell lung cancer: What is the role in the special populations?
|
Califano, R.
|
|
|
125 |
C |
p. 1-11
|
artikel
|
| 9 |
Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials
|
Robbrecht, Debbie G.
|
|
|
125 |
C |
p. 142-152
|
artikel
|
| 10 |
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
|
Hauschild, Axel
|
|
|
125 |
C |
p. 114-120
|
artikel
|
| 11 |
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
|
Latenstein, Anouk E.J.
|
|
|
125 |
C |
p. 83-93
|
artikel
|
| 12 |
Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer
|
Leighl, Natasha B.
|
|
|
125 |
C |
p. 49-57
|
artikel
|
| 13 |
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer
|
Mierzynska, Justyna
|
|
|
125 |
C |
p. 69-82
|
artikel
|
| 14 |
Suicide death among cancer patients: new data from northern Italy, systematic review of the last 22 years and meta-analysis
|
Ravaioli, Alessandra
|
|
|
125 |
C |
p. 104-113
|
artikel
|
| 15 |
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
|
Heng, Marilyn
|
|
|
125 |
C |
p. 130-141
|
artikel
|
| 16 |
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
|
Pasquier, David
|
|
|
125 |
C |
p. 22-30
|
artikel
|
| 17 |
Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature
|
Zhang, Li
|
|
|
125 |
C |
p. 12-21
|
artikel
|
Tijdschrift beschrijving